FTC official: policy steady even as drug prices spike

While sharp rises in generic and branded drug prices in recent years have led to increased attention from Congress and consumers, a Federal Trade Commission lawyer said the agency has kept policy steady.

Unlock unlimited access to all Global Competition Review content